Focal adhesion assembly and cell migration require myoferlin in PDAC cell lines

Area of Science:

• Oncology
• Cell Biology
• Biochemistry

Background:

• Pancreatic ductal adenocarcinoma (PDAC) presents a poor prognosis due to late detection and limited treatment options.
• Myoferlin overexpression in PDAC correlates with reduced patient survival, identifying it as a potential therapeutic target.
• Previous studies suggested myoferlin's role in cancer cell migration but lacked a clear mechanistic explanation.

Purpose of the Study:

• To investigate the precise role of myoferlin in pancreatic cancer cell migration.
• To elucidate the underlying molecular mechanisms by which myoferlin influences cell motility.

Main Methods:

• Analysis of myoferlin expression correlation with gene sets in PDAC patients.
• Myoferlin knockdown in PDAC cell lines.
• Electron microscopy and immunofluorescence to assess cytoskeleton and focal adhesion dynamics.
• Assessment of clathrin-mediated endocytosis markers.

Main Results:

• Myoferlin knockdown disorganized the actin cytoskeleton and reduced PDAC cell migration.
• Despite unchanged actin and EMT markers, myoferlin depletion increased focal adhesion components but decreased functional adhesions.
• Paxillin accumulation in the cytosol and reduced clathrin heavy chain indicated impaired focal adhesion recycling via clathrin-mediated endocytosis.

Conclusions:

• Myoferlin plays a critical role in regulating focal adhesion dynamics and recycling in PDAC.
• The study provides a consistent mechanism for myoferlin's contribution to PDAC cell migration and metastatic potential.
• Myoferlin represents a promising therapeutic target for improving pancreatic cancer treatment outcomes.